▲ The ISUOG World Congress will be held in Seoul, Korea from October 16 to 19

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, will be showcasing its AI-based diagnostic solutions at ISUOG (International Society of Ultrasound in Obstetrics and Gynecology) World Congress 2023 held in Seoul, South Korea from October 16 to 19.

As one of the most important academic societies in the field of obstetric and gynecologic ultrasound, ISUOG organizes annual congresses worldwide to share the latest technology and research findings. This year’s event, held for the first time in Seoul, will be attended by nearly 2,000 obstetricians and gynecologists from 126 countries.

Samsung Medison, a main sponsor of the event, will showcase Samsung’s AI diagnostic technology through the display of its premium ultrasound systems “HERA W10 Elite” and “V8,” diagnostic solution demonstrations and a symposium.

▲ Samsung Medison’s HERA W10 Elite(left) and V8 will be exhibited at ISUOG 2023

HERA W10 Elite is a premium ultrasound system equipped with a 27-inch OLED monitor, which exhibits less brightness variation across viewing angles than conventional LCD monitors. Its probe delivers superior resolution, allowing users to view high-contrast ultrasound images from various angles without compromising image quality.

At the conference, Samsung Medison will showcase AI-based diagnostic assistant solutions, including HeartAssist, which categorizes and provides measurement results for fetal heart diagnosis with a simple press of a button; and UterineAssist, which automatically measures the size and shape of the uterus helping to accurately examine and diagnose the uterus.

In addition, Samsung Medison will present AI-automated measurement functions such as BiometryAssist and ViewAssist, which measure and automatically annotate fetal growth indicators by extending the items previously measured only in the 2nd trimester (14-27 weeks) to the 1st trimester (1-13 weeks) in accordance with the newly revised ISUOG guidelines in February 2023.

“Using the BiometryAssist feature, fetal weight can be measured with professional accuracy up to 48 hours before delivery, and the measurement time can be dramatically reduced,” said Professor Mar Gil of Torrejón University Hospital, Spain, in an abstract of the study available for publication at the conference.

At the conference, Samsung Medison will also introduce an upgraded version of “5D CNS (Central Nervous System)+,” a convenient feature for fetal brain examination.

A positive reception is anticipated at the conference due to its automatic provision of nine essential cross-sections of the fetal brain, including the coronal and sagittal planes and six measurements necessary for diagnosis – head circumference and diameter, with high accuracy.

Other features such as SonoSync, which specializes in remote consulting and training, and S-Hub, an IT solution for hospital resource management, will be on display to medical professionals from around the world.

Samsung Medison will hold symposia on “Obstetrics” and “Gynecology” on October 17 and 18, respectively, to present research findings on the clinical utility of features that help diagnose the heart and brain of a fetus and endometriosis.

During the “Fetal Therapy and Telesonography” session in the “Obstetrics” symposium, Dr. Ruben Quintero from The Fetal Institute in the United States will present a case where SonoSync, a real-time ultrasound image-sharing solution with remote control ability, saved the life of a mother and her newborn in a case of misdiagnosed fetal distress.

In the “Gynecology” symposium, Professor Tom Bourne from Imperial College, U.K., will present his research on ovarian tumors using CrystalVue and MV-Flow features.

“Samsung is continuously developing AI technologies that improve diagnostic efficiency so that doctors can focus more on patient care,” said Jinyong Lee, Head of the AI Vision Group at Samsung Medison. “We are continually striving to develop technologies that can be utilized in the field of obstetrics and gynecology to contribute to improving maternal and fetal health.”

The conference, which is held for the first time in South Korea, is also the first offline event since the end of the COVID-19 pandemic. Samsung Medison is participating as the main sponsor and engaging in various academic activities, including the Samsung-ISUOG webinars and the Pre-Congress.

▲ ISUOG Industry Webinar schedule

For more information on Samsung’s Healthcare division, its subsidiaries and products please visit www.samsunghealthcare.com.

During this congress, Samsung will be showcasing the clinical values and efficiencies of the Artificial Intelligence (AI)-based diagnostic solutions through various scientific programs.

Samsung’s symposium will be held on September 18^th at 12:35 p.m. This event will also run online under the theme of “Samsung’s Advanced AI and Remote Diagnosis Solutions.” Prof. Julien Stirnemann (Necker Hospital, France) will deliver research results on the clinical values of two AI diagnostic solutions: BiometryAssist which measures the growth and condition of a fetus and HeartAssist which improves workflow when diagnosing a fetal heart.

Professor Antonia Testa (Scientific Director of the Center for Ultrasound in Gynecological Oncology “Class Ultrasound” of the Agostino Gemelli University Hospital, Rome, Italy) will be demonstrating her experience with SonoSync, a real-time ultrasound image-sharing solution during Samsung’s Symposium. She will be presenting the simplicity and benefits of image sharing as a second opinion by remotely accessing a HERA W10 system at Gemelli Hospital, Rome from the ISUOG venue in London.

“This will be a live demonstration of a patient scan, voice communication with a sonographer, and remote measurements executed in London. This advancement in ultrasound environment using SonoSync brings telesonography into reality,” said Professor Antonia Testa. “I believe Samsung’s forward-thinking technologies and advanced developments in ultrasound in recent years are quite impressive.”

In addition, Samsung will be hosting four onsite Hospitality Suite programs with lectures and live demonstrations for customers to experience high performance diagnostic solutions such as MV-Flow which is used to visualize the slow flow of microvascular structures and the existence of micro-blood-flow.

The onsite scientific programs, Samsung will display online webinars at six times during the congress through ISUOG’s virtual platform. More details on Samsung’s scientific programs can be found on the ISUOG website and the Samsung’s Healthcare website (www.samsunghealthcare.com).

Samsung will also showcase its premium ultrasound system for obstetrics and gynecology known as HERA W10 and V8 which systems includes Intelligent Assist (AI diagnostic solutions), as well as V7, high-end ultrasound systems that can be used in various medical specialties and also with premium AI diagnostic solutions.

As far as the name, the “V” in “V7” stands for “Versatile,” meaning that this system can be used in various medical fields such as obstetrics, gynecology, radiology, orthopedics, cardiology and more. The V7 hosts features and solutions seen on premium ultrasound systems.

※ The diagnostic solutions provided with V8 and V7 are the same, but there are some differences in their image resolution.

Kyu Tae Yoo, Senior Vice President, Head of Sales & Marketing Team of Samsung Medison stated “This is a very meaningful time for us as we share the clinical values of our ultrasound AI-based diagnostic tools and features in collaboration with so many prominent medical professionals. We will continuously proceed forward introducing diagnostic solutions for the medical professionals and patients.”

For more information on Samsung’s Healthcare division, its subsidiaries and products please visit https://www.samsunghealthcare.com.

Exhibition products at ISUOG 2022 (from left — V7, HERA W10, V8)

SonoSync — Solution to overcome spatial constraints when performing ultrasound exams

About Samsung Medison

Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

* Content has been updated as of February 10, 2023 to more accurately reflect product information.

“This has been a momentous year for Samsung. We have worked to advance our solutions by leveraging high computing power and artificial intelligence (AI) technologies,” said David Legg, Vice President, Digital Radiography and Ultrasound, NeuroLogica. “We will be deploying AI features in each of our products to provide benefits to healthcare professionals and patients alike.”

Ultrasound

At the event, Samsung will showcase its new V8, which is a premium ultrasound system that provides enhanced image quality, usability and convenience for ultrasound professionals. Crystal Architecture is the core of the V8’s image clarity and penetration and is built upon the combination of innovative beamforming (CrystalBeam), sophisticated image processing (CrystalLive) and advanced S-Vue Single Crystal Transducers to produce clear, uniform and high-resolution images.

The feature-packed device includes two new AI functions, one being NerveTrack, which detects nerves and provides nerve location information in real-time to anesthesiologists and expert practitioners. The function is designed to provide users with accurate nerve detection, faster image processing and better workflow support. The second AI function is UterineAssist, which detects tissue changes and assists the user in taking measurements of the uterus. With these and other new tools, the V8 delivers a new level of versatility and value to a wide range of diagnostic medical ultrasound departments.

Samsung has also worked to advance its ultrasound solutions for women’s health. Recently, the Hera W9 and W10 received Food and Drug Administration (FDA) 510(K) clearance for its new AI functions, which gives the operator the ability to measure anatomical structures and analyze imaging, providing useful information to aid diagnosis.

New features include:

• HeartAssist: A deep learning-based function that provides classification of ultrasound images to display measurements. The feature recognizes various views and proposes caliper placements and corresponding measurements allowing users to save time with measurement proposals and increase examination efficiency by reducing keystrokes.
• ViewAssist: A deep learning-based function that classifies ultrasound images to deliver key scanning views and provides annotations. The feature recognizes a range of views, proposes corresponding anatomy annotations and initiates measurements.
• BiometryAssist: An automatic solution for biometric measurement that can be modified by the user. It enables users to measure fetal growth parameters with one click while maintaining exam consistency.

Digital Radiography

Samsung is also showcasing its premium digital mobile X-ray, the AccE GM85, which delivers unparalleled performance and gives users better diagnostic confidence while improving workflow. Recently, Samsung received FDA 510(k) clearance for its Auto Lung Nodule Detection (ALND) tool, which can be utilized in the AccE GC85A and in other systems. The ALND is provided as an on-device computer-assisted detection (CADe) software that uses an AI algorithm to detect pulmonary nodules between 10 and 30mm in size.¹

The benefits of ALND include:

• Aids the user in the diagnostic process by indicating the location of suspected lung nodules on chest X-ray images (posteroanterior chest radiographs).
• Offers the option (Autorun) to automatically perform nodule detection immediately after chest X-ray imaging in addition to PACS transmission options to suit the hospital environment, both of which simplify the user’s workflow.
• The ALND has been clinically verified by multiple university hospitals and has been approved with a sensitivity of 80% or more.² As part of Samsung’s commitment to advancing diagnostic radiology using AI, Samsung will expand the uses of the chest CADe solution and continue improving diagnostic accuracy and workflow.

Computed Tomography

Also featured at RSNA is the OmniTom^® Elite – a mobile computed tomography (CT) scanner that delivers high-quality non-contrast CT, CT angiography and CT perfusion scans at point-of-care. The OmniTom Elite CT boasts a small footprint and high-resolution image quality. The advancements of the scanner help to optimize diagnostic confidence, speed and workflow across departments, such as neurosurgery, pediatric imaging, critical care, diagnostic radiology and more.

Earlier this year, NeuroLogica announced that the OmniTom Elite with Photon Counting Detector (PCD) technology will be piloted by Massachusetts General Hospital, bringing CT imaging to the patient’s point-of-care. Pending FDA 510(k) clearance, the hospital is testing the OmniTom Elite with PCD to monitor post-trauma and post-surgical patients.

The OmniTom Elite’s ability to provide versatile, real-time mobile imaging enables healthcare providers to administer point-of-care CT to critical patients without the need to transport them to a separate department. The mobile unit will decrease the time it takes to diagnose and initiate treatment for patients in the ICU. During the pilot stage for the OmniTom Elite with PCD, Massachusetts General Hospital will guide best practices and evaluate use cases for the novel system.

Visit Samsung at Booth #6952.

Samsung will showcase its premium diagnostic imaging solutions in ultrasound, digital radiography and mobile computed tomography at the Radiological Society of North America (RSNA) 2021 Annual Meeting.

About Samsung Medison Co., Ltd.

Samsung Medison is a global leading medical device company, founded in 1985. With a mission to bring health and well-being of people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

About NeuroLogica Corp.

NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of mobile computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies is used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. For more information, please visit http://www.NeuroLogica.com.

* Content has been updated as of February 10, 2023 to more accurately reflect product information.

¹ ALND cannot be used on patients who have lung lesions other than abnormal nodules.

² Y. Sim et al, Deep Convolutional Neural Network-based Software Improves Radiologist Detection of Malignant Lung Nodules on Chest Radiographs. Radiology, 2020

“Since the launch of the ‘Intelligent Assist’ solution in 2020, we have been actively listening to the needs of our customers and have reflected the needs of the market into our enhanced AI-based image processing technologies and diagnostic assistance functions,” said Won-Chul Bang, Vice President, Head of Customer Experience Team at Samsung Medison. “We will actively introduce various ultrasound diagnosis solutions to meet customers’ needs in the future preemptively.”

Samsung is launching its enhanced ‘Intelligent Assist’ software in its premium ultrasound device, HERA W10, and will be presenting its clinical values for “Improving Accuracy and Efficiency” for fetal anomaly detection using its AI solutions during the online symposium on October 17^th.

‘Intelligent Assist’ solution includes ‘Biometry Solution’ for assessment of the fetal growth and ‘Fetal Heart Solution’ for the assessment of the fetal heart.

‘Biometry Solution’ recognizes images such as the fetal head, abdomen, lower extremities and others and measures the fetal growth and development while the ‘Fetal Heart Solution’ recognizes the view of the fetal heart, annotates the images and measures the necessary fetal heart structures for a thorough fetal heart anomaly assessments.

During the symposium, Aris Papageorghiou, Clinical Research Director of the Maternal and Perinatal Health Institute at Oxford UK and the professor in obstetrics and fetal medicine at St George’s University Hospitals UK, will be introducing his clinical experiences with Samsung’s ‘Intelligent Assist’ solutions.

Hye-Sung Won, professor of the Department of Obstetrics and Gynecology at Asan Medical Center, Korea, will introduce the MPI+ that semi-automatically measure LV MPI and RV MPI to analyze the fetal heart function. She will also be presenting her findings of the feasibility and reliability of ‘Fetal Heart Solution’ in automatically providing complex fetal heart view image classifications and fetal heart structural measurements.

In addition, Samsung will be introducing its high-end versatile ultrasound device ‘V8’, first released on September 30^th, at the virtual exhibition hall during ISUOG 2021.

‘V8’ will include some of the enhanced solutions that are dedicated to the premium ultrasound system such as MV-Flow, a novel alternative to power Doppler for visualizing the slow flow of micro-vascularized structures, and LumiFlow, three-dimensional visualization of blood flow which helps the user understand the structure of small vessels intuitively. ‘V8’ will also include some of the ‘Intelligent Assist’ solutions to cater to the needs of the larger busy hospitals.

For more information on Samsung’s healthcare division, its subsidiaries and products, please visit https://www.samsunghealthcare.com.

The image delineates that the fetal head is automatically recognized and measured along with the fetal growth when ‘Biometry Solution’ is executed.

The feature automatically recognizes and annotates the anatomy of the fetal heart and displays measured values when the ‘Fetal Heart Solution’ is executed.

About Samsung Medison
Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

“It’s very meaningful to launch the V8, a new premium medical device that addresses many customer needs,” said Won-Chul Bang, Vice President, Head of Customer Experience Team, Samsung Medison. “We expect V8 to become a flagship product of premium ultrasound systems as it is uniquely designed to cover different medical specialties.”

V8’s “V” stands for “Versatile,” meaning that the advanced functions from premium ultrasound systems dedicated to specific departments such as obstetrics, radiology, orthopedics and cardiology have been implemented.

Several diagnostic assistance functions of a premium ultrasound system for obstetrics and gynecology include MV-Flow which is suitable for observing the presence of microvascular blood flow, low-velocity blood flow and LumiFlow which provides three-dimensional visualization of blood flow in a two-dimensional image, allowing the medical staff a more realistic assessment of the vascular structures and flow.

For radiology, V8 is equipped with S-Shearwave Imaging which provides information about tissue stiffness as a result of disease using ultrasonic transverse elasticity. V8 also features S-Fusion which allows synchronous alignment of medical images of ultrasound with one or more cross-sectional studies such as MRI which are instantly reconstructed in the corresponding plane.

On the other hand, it is also expected to be equipped with a NerveTrack which has been cleared by the U.S. Food and Drug Administration (FDA) as an AI medical device and can be used to treat musculoskeletal diseases that track nerve locations in pain areas in real time.

In addition, by introducing a 23.8″ LED monitor and a 14″ high-sensitivity touch panel, user convenience has been enhanced to perform various procedures.

The screen that automatically tracks the nerve’s location on the wrist in real time with the NerveTrack function is executed.

About Samsung Medison

Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

* Content has been updated as of February 10, 2023 to more accurately reflect product information.